US 10508106
Bicyclic BET bromodomain inhibitors and uses thereof
granted A61PA61P25/28A61P31/18
Quick answer
US patent 10508106 (Bicyclic BET bromodomain inhibitors and uses thereof) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Dec 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61P, A61P25/28, A61P31/18, A61P35/00, A61P35/02